Rekom Biotech

Rekom Biotech is a company that specializes in the production of recombinant antigens and polyclonal antibodies for the in vitro diagnosis of infectious diseases and allergies. Several key factors make us stand out. Choose us as your raw material supplier, you will not regret it! 🔗https://shorturl.at/VGMTJ #rekombiotech #RecombinantProteins #PolyclonalAntibodies

The holiday season is here! 🎄 We’ll be taking a short break from December 23rd to January 6th to recharge, reflect, and spend time with loved ones. But don’t worry—we’re not slowing down on plans for next year. 🚀 We’ve got some exciting things in the pipeline, and we can’t wait to share them with you! For now, we want to thank you for an incredible year and wish you a joyous holiday season. See you in 2025!

🎄✨ Spreading Holiday Cheer at Rekom Biotech! ✨🎄 Today, we came together as a team to celebrate the holiday season with a festive Christmas lunch. It was a wonderful opportunity to reflect on our achievements, share laughter, and strengthen the bonds that make Rekom Biotech a great place to work. From all of us at Rekom Biotech, we wish you a Merry Christmas and a prosperous New Year! May 2025 bring new opportunities, collaborations, and successes for everyone. #Christmas2024 #RekomBiotech #Teamwork #HolidaySeason #Gratitude

🛑 Oropouche Virus Disease: An Emerging Concern in the Americas The World Health Organization has issued an alert about cases of Oropouche virus disease in the Region of the Americas. This mosquito-borne illness, often under the radar, is gaining attention due to its potential public health implications. 📖 Learn more in the WHO release: https://shorturl.at/W53VU. Here’s what you need to know: 1️⃣ Symptoms: Often mistaken for other febrile illnesses, it includes fever, headache, rash, and joint pain. 2️⃣ Transmission: Primarily spread by insects like midges or mosquitoes, with risks heightened in densely populated areas. 3️⃣ Response Needed: Increased awareness, research, and prevention strategies are vital to curb its spread. Let’s raise awareness about diseases that often go unnoticed but can have significant public health consequences. How can we better prepare and respond to emerging health threats like this?🔄 Share this post to spread awareness. #OropoucheVirus #GlobalHealth #InfectiousDiseases #WHO #PublicHealth

The FDA is shaking up the rules for medical device cybersecurity. This is big news for developers, manufacturers, and healthcare professionals. If you’re working on a medical device, here’s what you need to know: The FDA’s new cybersecurity requirements will directly impact how devices are designed, tested, and deployed. The goal? Protect patient safety by reducing risks from cyber threats. But here’s the challenge: ▪️ Many companies still see cybersecurity as a “check-the-box” activity. ▪️ The new requirements mean it’s time to get serious about proactive, ongoing security measures. What does this mean for your business? ✔️ More robust premarket submissions: Devices must include a detailed cybersecurity plan. ✔️ Lifecycle security: It’s not just about launch anymore; devices need ongoing updates and monitoring. ✔️ A higher bar for compliance: Meeting these standards might require restructuring processes and retraining teams. Want to dig deeper? Check out this excellent breakdown of the new requirements by MethodSense: https://shorturl.at/g4bbg. The good news? These changes create a safer ecosystem for patients and providers, and they give forward-thinking companies a chance to differentiate their products in the market. ❔ So, here’s my question: How is your team preparing to meet the FDA’s new cybersecurity standards? Drop your insights below 👇 – let’s discuss how we can all adapt and thrive in this new regulatory landscape. P.S. If you found this helpful, feel free to reshare to spread the word! ♻️ #Cybersecurity #MedicalDevices #FDA #HealthcareInnovation #MedTech #Compliance #PatientSafety #CyberThreats #RegulatoryUpdates #DigitalHealth

Choosing the right expression system for recombinant protein production can feel overwhelming (But it doesn’t have to be) At Rekom Biotech, we've been mastering Escherichia coli and Pichia pastoris systems for efficient and cost-effective protein production. Now, we’re taking the next step. ✅ We're introducing Baculovirus systems for more complex proteins. ✅ In the near future, we’ll be expanding into mammalian cells for proteins requiring higher fidelity and post-translational modifications. Why does this matter? Not all proteins are created equal. And not all expression systems deliver the same results. Here’s a quick guide: ▪️ E. coli: Fast and affordable, perfect for simple proteins. ▪️ Pichia pastoris: Great for larger, more complex proteins. ▪️ Insect cells: Ideal for proteins requiring complex folding or glycosylation. ▪️ Mammalian cells: The gold standard for therapeutic proteins with human-like modifications. We believe in evolving to meet your needs. What expression systems are you using? And which do you see as the future of recombinant protein production? Let’s talk science. Let’s talk solutions. P.S. Follow us for updates as we grow our capabilities in 2024 and beyond!

🎄 Merry Christmas and Happy New Year! 🎆 As we celebrate this season of joy and reflection, we want to express our gratitude for all the connections, collaborations, and moments that shaped this year. Let’s carry the spirit of giving, learning, and growing into the year ahead. May 2024 bring you happiness, health, and success in every way that matters. Here’s to new beginnings, meaningful connections, and endless opportunities! P.S. What’s one highlight of your year? Share below—let’s celebrate together! #Gratitude #HappyHolidays #NewYear2024 #GetREKOMended

What’s stored in Wuhan lab freezers? A new chapter in the #COVID19 origin story The COVID-19 pandemic reshaped our world, but questions about its origins remain. Shi Zhengli—the virologist at the heart of the Wuhan lab-leak theories—shared critical findings at a conference in Japan. She presented the genetic sequences of 56 coronaviruses collected from bats in southern China over the past two decades. Her findings? None of these viruses are closely related to SARS-CoV-2, the virus behind COVID-19. Key takeaways: 1️⃣ Shi’s research supports claims that the Wuhan Institute of Virology (WIV) didn’t possess bat-derived viruses that could be precursors to SARS-CoV-2. 2️⃣ The closest relatives to SARS-CoV-2 were found in bats from Laos and Yunnan, China, and likely diverged from the virus years—if not decades—ago. This evidence adds weight to her long-standing assertion: the WIV lab wasn’t involved with SARS-CoV-2 prior to the pandemic. This highlights the importance of transparency and rigorous science in addressing global concerns. It also underscores how vital it is to focus on the lessons learned to better prepare for future pandemics. 🔗 https://lnkd.in/dY3RAk8y 🤔 What are your thoughts on the latest findings? Do they shift your perspective on the origins of COVID-19? Let’s continue the dialogue around what matters: better science, better preparedness, and a healthier world. #Virology #PandemicPreparedness #PublicHealth #ScienceMatters #GlobalHealth #TransparencyInScience

Science isn’t just about discovery. It’s about sharing discovery. 🧪 When we explore the unknown, we uncover knowledge that can change lives. But the real magic happens when we share that knowledge—when we inspire curiosity, ignite passion, and build a community where learning never stops. In diagnostics, this principle is our guiding light. We aim not only to advance the science but to empower others through what we learn. Because at the heart of it, science is a conversation. A spark. A connection. Let’s keep the flame burning. 🔬✨ 🔗https://shorturl.at/6ugOC #ScienceOutreach #InVitroDiagnostics #IVD #GetREKOMended

🧪 Whooping Cough is Back: An Opportunity and Responsibility for IVD Manufacturers (Here’s why this matters more than ever) Whooping cough, or pertussis, is making a troubling resurgence. Early detection is key to controlling its spread, and IVD testing is on the frontline. Why should IVD manufacturers care? 🔬 Market Need: Rising cases mean growing demand for rapid, reliable diagnostic tests. 🔬 Public Health Role: Accurate diagnostics can save lives by enabling earlier treatment and reducing transmission. 🔬 Innovation Opportunity: This resurgence highlights the need for more sensitive, accessible point-of-care solutions. What are the priorities for the next generation of pertussis tests? ✔️ Faster results to aid immediate clinical decisions. ✔️ High sensitivity to minimize false negatives. ✔️ Scalability to meet surges in demand. IVD companies have a unique role: advancing healthcare while addressing global health challenges. The question isn’t just how to meet the demand but how to innovate for a healthier future. 🔗 Read more about the resurgence of whooping cough and its implications here: https://shorturl.at/zgVqT. 👉 How are you preparing for the next wave of diagnostic needs? Share your thoughts below. #IVDManufacturing #DiagnosticInnovation #WhoopingCough #PublicHealth #HealthcareInnovation